FREE LIVE WEBINAR We would like to invite you to join us on Wednesday, October 1st at 11:00am EST for a special discussion on the week 16 results of the VELA Phase 3 hidradenitis suppurativa program with the Nanobody® sonelokimab. We’re excited to have Dr. Martina Porter as our expert speaker! Dr. Porter specializes in treating immune-mediated dermatologic conditions such as hidradenitis suppurativa, psoriasis, atopic dermatitis, and IBD-related dermatoses. She also leads both investigator-initiated and Phase 2/3 industry-sponsored clinical trials in these areas. 📅 Date: Wednesday, October 1st 🕚 Time: 11:00am EST 🖥️ Online (FREE to attend!) 👉 Register here: https://lnkd.in/ePpSbsbX Don’t miss the chance to hear these important insights firsthand!
Coleman Research
Information Services
New York, NY 38,234 followers
Make Insightful Connections Possible
About us
For 20 years, the world’s leading institutional investors, consultancies, and corporations have trusted Coleman Research to gain insights from specialized industry experts. We are now a subsidiary of VisasQ. We help the world's leading organizations make more informed decisions, with insightful connections to senior, hard-to-find experts around the world. Together with VQ, our network includes 400,000 senior-level experts in all regions and industries, with great depth in Information Technology. Clients have 24/7 coverage and support from dedicated teams in New York, Tokyo, Hong Kong, Singapore, London, Raleigh, and Los Angeles with more than 350 employees.
- Website
-
http://www.colemanrg.com
External link for Coleman Research
- Industry
- Information Services
- Company size
- 201-500 employees
- Headquarters
- New York, NY
- Type
- Public Company
- Founded
- 2003
- Specialties
- Business & Financial Services, Consumer Goods & Services, Energy & Industrials, Healthcare, Legal & Regulatory, Tech, Telecom, & Media, Expert Network, Information Technology, ESG, M&A, Corporate Strategy, and Expert Insights
Locations
Employees at Coleman Research
-
Ryan Joswick
CEO at RJA | Ex-Fortune 500 SVP
-
Tom Walsh
CEO/ Founder at Renetech AB
-
Alexandre Gomes da Silva
Strategic Executive | Driving Digital Transformation & Customer Experience | Achieved 30% Cost Savings & 10-point NPS Boost in LATAM Markets
-
Eric B Stein
Experienced Media & Tech Entrepreneur with Focus in Digital Distribution, Licensing, Over-The-Top (OTT), FAST Distribution, SaaS Software, Strategy…
Updates
-
We’re honored to be featured in The Japan Times’ Sustainable Japan series, which highlights VisasQ’s mission to make insightful connections possible between global leaders and industry experts. Read the full article: https://lnkd.in/gdmiVj4t
-
At Coleman, our teams custom recruit on all of your projects, searching for the best, most qualified candidates based on your exact project specifications. One out of every five expert consultations we facilitate are with an expert who was custom-recruited specifically for your needs. Our average recruiting time is less than 24 hours, and that timeline continues to drop as we integrate AI into our platform and learn how to better anticipate your team's research needs. https://lnkd.in/evZyBET4
-
-
Reflecting on our April 2024 seminar on the GLP-1 market, did you know the global GLP-1 space has more than doubled in size and now exceeds $60 billion in annual sales as of 2025? Our expert, Jeremy Shepler, led the pre-commercialization plans and marketing strategies for OZEMPIC while he was at Novo Nordisk from 2015 to 2023. Some of the topics discussed include: • Background of GLP-1s and the split between Weight Loss vs Type 2 Diabetes • Drugs in the market: Ozempic, Wegovy, Mounjaro, Zepbound, Tirzepatide, Victoza, etc. • What is the drug development process and how do these drugs work? • The commercialization playbook, challenges, and the establishment of the market The seminar video can be found at the link below and the transcript can be found in the "Seminar" section of our website. https://vid.us/mxk8gp
-
-
As an expert, you will contribute your knowledge to world-class companies and hear the questions people are asking about your industry. When our clients come to us with questions, we source from our extensive global network to find them experts like you who can provide context and insight. Then, we connect you through a brief online consultation or an in-person meeting, after which you will receive payment.
-
-
Coleman Research reposted this
Happy Employee Appreciation Day! Today, we celebrate the incredible dedication, hard work, and contributions of our employees. Your passion and commitment drive our success, and we truly appreciate everything you do. Thank you for your impact, your teamwork, and your constant pursuit of excellence. Our success wouldn't be possible without you! #employeeappreciationday
-
-
Happy Employee Appreciation Day! Today, we celebrate the incredible dedication, hard work, and contributions of our employees. Your passion and commitment drive our success, and we truly appreciate everything you do. Thank you for your impact, your teamwork, and your constant pursuit of excellence. Our success wouldn't be possible without you! #employeeappreciationday
-
-
With our global network of 650,000+ experts, we deliver hard-to-find respondents, quickly and easily, to help get the insights you need. VISASQ/COLEMAN provides white-glove support at every stage of your project from thought partnership to project fulfillment. We’re here whenever you need us, with expertise gained from thousands of quantitative studies. Because all of our experts have been custom-selected to be part of our network, we have full control of employment history verification which gives our clients superior data quality. All survey data undergoes rigorous review to ensure you only receive the highest quality results.
-